
An IDE clinical trial to assess CCM therapy in symptomatic heart failure patients with a higher EF (40-60%). RT ≠ endorsement. #HFpEF @modulateHF
Marlton, NJ
Joined March 2021
- Tweets22
- Following104
- Followers66
- Likes223

An IDE clinical trial to assess CCM therapy in symptomatic heart failure patients with a higher EF (40-60%). RT ≠ endorsement. #HFpEF @modulateHF